Straumann Holding AG STRAUMANN HOLDING ORD SHS
Straumann Holding AG STRAUMANN HO.../ CH1175448666 /
0QMV
|
15/11/2024 18:11:46
|
Var.
-1.74
|
Volume |
Denaro- |
Lettera- |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
|
110.88CHF
|
-1.54%
|
5,679
Fatturato: 631,238.75 |
-Quantità in denaro: - |
-Quantità in lettera: - |
17.67 bill.CHF |
0.77% |
71.95 |
Descrizione business
Headquartered in Basel, Switzerland, Straumann (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and biomaterials for use in tooth replacement and restoration solutions or to prevent tooth loss.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Guillaume Daniellot |
| Consiglio di amministrazione |
| Yang Xu, Jason Forbes , Patrick Loh , Alastair Robertson, Sébastien Roche, Aurelio Sahagun, Matthias Schupp, Sara Dalmasso, Thomas Friese, Holger Haderer, Florian Kirsch |
| Consiglio di sorveglianza |
| Petra Rumpf, Dr. Thomas Straumann, Marco Gadola, Regula Wallimann, Xiaoqun Clever-Steg, Stefan Meister, Olivier Filliol |
Dati aziendali
| Name: |
Straumann Holding AG |
| Indirizzo: |
Peter Merian-Weg 12,CH-4052 Basel |
| Telefono: |
+41-61-965-1111 |
| Fax: |
+41-61-965-1101 |
| E-mail: |
info@straumann.com
|
| Internet: |
www.straumann.com |
| Industria: |
Healthcare |
| Settore: |
Medical Products |
| Sub settore: |
Advanced Medical Devices |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
57.90% |
| Data dell'IPO: |
01/01/1998 |
Company calendar
|
CW 8 | 19/02/2025
4th Quarter/Annual Report
|
